[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100293799":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":88,"collaborators":18,"id":92,"slug":18,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":18,"eligibilityCriteria":97,"healthyVolunteers":93,"sex":98,"minAge":99,"maxAge":100,"enrollmentInfo":101,"targetDuration":18,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":110,"overallStatus":115,"whyStopped":18,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":125},{"fullName":5,"class":6},"Hepatopancreatobiliary Surgery Institute of Gansu Province","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Injection of 37℃ contrast agent","EXPERIMENTAL","Nonionic contrast agent is heated to 37℃ during ERCP when injection of contrast agent",[13],"Procedure: Injection of 37℃ contrast agent",{"label":15,"type":16,"description":17,"interventionNames":18},"Injection of normal contrast agent","NO_INTERVENTION","Normal temperature nonionic contrast agent can be used in ERCP when injection of contrast agent",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"PROCEDURE","Nonionic contrast agent is heated to 37℃ in a incubator when injection of contrast agent",[9],[25],{"name":26,"affiliation":5,"role":27},"Xun Li, M.D., Ph. D.","STUDY_CHAIR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Wenbo Meng, M.D., Ph. D.","CONTACT","+8613919177177","mengwb@lzu.edu.cn",{"name":26,"role":31,"phone":35,"phoneExt":18,"email":36},"+8613993138612","drlixun@163.com",[38,58,73],{"facility":39,"status":18,"city":40,"state":41,"zip":42,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"The first hospital of Lanzhou university","Lanzhou","Gansu","730000","China",{"type":45,"coordinates":46},"Point",[47,48],103.83987,36.05701,{"lat":48,"lon":47},[51,55],{"name":52,"role":31,"phone":53,"phoneExt":18,"email":54},"Wence Zhou, M. D.","+8609318356919","zhouwc129@163.com",{"name":56,"role":31,"phone":57,"phoneExt":18,"email":33},"Wenbo Meng, M. D.","+8609318356213",{"facility":59,"status":18,"city":60,"state":61,"zip":62,"country":43,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"The first affiliated hospital of Xi 'an jiaotong university","Xi'an","Shaanxi","710061",{"type":45,"coordinates":64},[65,66],108.92861,34.25833,{"lat":66,"lon":65},[69],{"name":70,"role":31,"phone":71,"phoneExt":18,"email":72},"Hao Sun, M. D.","+86 13891813691","sunhaoxjfy@126.com",{"facility":74,"status":18,"city":75,"state":76,"zip":77,"country":43,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Tianjin Nankai Hospital","Tianjin","Tianjin Municipality","300100",{"type":45,"coordinates":79},[80,81],117.17667,39.14222,{"lat":81,"lon":80},[84],{"name":85,"role":31,"phone":86,"phoneExt":18,"email":87},"Zhenyu Wang, M. D.","+86 15302021661","Wangzytj@163.com",{"type":89,"investigatorFullName":90,"investigatorTitle":91,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Xun Li","M.D., Ph. D, Director.","100293799",false,"NCT03104569","Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma","Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma: A Prospective Double-blind Multicenter Randomized Controlled Study","Inclusion Criteria:\n\n* Type Ⅰ、Ⅱ、Ⅲ、Ⅳ of Hilar Cholangiocarcinoma;\n* Age: 18\\~90 years old;\n* Underwent diagnostic and therapeutic ERCP;\n\nExclusion Criteria:\n\n* Coagulation dysfunction(INR\\>1.3) or\u002Fand low peripheral blood platelet count （PLT \\\u003C50x10\\^9\u002FL）;\n* Preoperative acute cholangitis;\n* Preoperative acute pancreatitis;\n* Preoperative hemobilia or hemorrhage of digestive tract;\n* Preoperative liver failure;\n* Combined with Mirizzi syndrome and intrahepatic bile duct stones;\n* Preoperative malignant tumor of biliary system such as carcinoma of head of pancreas, gallbladder carcinoma;\n* Biliary-duodenal fistula confirmed during ERCP;\n* A history of reconstructive surgery for upper digestive tract except Billroth Ⅰand a history of cholangioenterostomy including cholangio-jejunostomy and side to side anastomosis of the bile duct and duodenum;\n* Previous ERCP;\n* Pregnant women","ALL","18 Years","90 Years",{"count":102,"type":103},100,"ESTIMATED","INTERVENTIONAL",[106],"NA","The purpose of this study is to determine the effect of normal temperature and 37℃ non-ionic contrast agent acting on ERCP-related cholangeitis after endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of hilar cholangiocarcinoma.",[109],"Cholangitis",[111,112,113,109,114],"ERCP","Contrast agent","Hilar cholangiocarcinoma","Nonionic","NOT_YET_RECRUITING","2025-12-19",{"date":118,"type":119},"2025-12-26","ACTUAL",{"date":121,"type":103},"2026-04-01",{"date":123,"type":103},"2028-12-01",{"name":5,"class":6},3]